|Publication number||US7067169 B2|
|Application number||US 10/454,406|
|Publication date||Jun 27, 2006|
|Filing date||Jun 4, 2003|
|Priority date||Jun 4, 2003|
|Also published as||CA2563299A1, CA2563299C, DE602004019938D1, EP1656164A1, EP1656164B1, US7341756, US7648726, US20040249472, US20060141002, US20080152785, WO2005000373A1|
|Publication number||10454406, 454406, US 7067169 B2, US 7067169B2, US-B2-7067169, US7067169 B2, US7067169B2|
|Inventors||Jiankai Liu, Yuhong Huang, Ichiro Nishimura|
|Original Assignee||Chemat Technology Inc.|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (113), Non-Patent Citations (5), Referenced by (7), Classifications (7), Legal Events (5) |
|External Links: USPTO, USPTO Assignment, Espacenet|
Coated implants and methods of coating
US 7067169 B2
A method including forming a first coating layer derived from an alkoxide on a substrate having a dimension suitable for an implant and forming a second coating layer on the first coating layer that promotes osseointegration. An apparatus comprising a substrate having a dimension suitable as a medical or dental implant and a coating on a surface of a first coating layer derived from an alkoxide and a second coating layer that promotes osseointegration.
1. A method comprising:
forming a first coating layer from a condensation reaction of an alkoxide, the first coating layer comprising a ligand comprising a positively charged moiety on a substrate having a dimension suitable for an implant; and
applying a second coating on the first coating layer, the second coating comprising a hydroxyapatite material having a property that promotes osseointegration.
2. The method of claim 1, wherein the substrate is a metal material and the metal material is selected from the group consisting of tantalum, cobalt, chromium, titanium, a cobalt alloy, a chromium alloy, or a titanium alloy.
3. The method of claim 2, wherein the substrate is a metal material and the metal material comprises titanium.
4. The method of claim 3, wherein the metal material is a titanium alloy comprising six percent aluminum and four percent vanadium by weight.
5. The method of claim 1, wherein the positively charged moiety comprises an amine moiety.
6. The method of claim 1, wherein forming a first coating layer comprises contacting the substrate with aminopropyl-trimethoxysilane.
7. The method of claim 1, wherein the first coating layer comprises a positively charged surface.
8. The method of claim 1, wherein applying the second coating comprises contacting the substrate with a coating solution comprising nanosized hydroxyapatite particles.
9. The method of claim 8, wherein the coating solution comprises a mixed solvent comprising alcohol, dH2O, ether, and a base.
10. The method of claim 9, wherein the coating solution has a pH of 7 to 10.
11. The method of claim 1, wherein prior to applying the second coating, the method comprises drying the first coating layer.
12. The method of claim 11, wherein drying comprises drying for one minute at room temperature.
13. The method of claim 1, further comprising drying the second coating at a temperature of room temperature to 100° C.
14. The method of claim 1, wherein the first coating layer comprises a single molecular layer.
15. The method of claim 1
, wherein applying the second coating comprises applying nanosized hydroxyapatite particles, and after applying the second coating, the method further comprises:
forming a single layer of nanosized hydroxyapalite particles.
16. The method of claim 1, wherein a surface of the second coating is negatively charged.
17. An apparatus comprising:
a substrate having a dimension suitable as a medical or dental implant; and
a coating on a surface of the substrate, the coating comprising a first, coating layer derived from a condensation reaction of an alkoxide having a ligand comprising a positively charged moiety and a different second coating layer on the first coating layer and comprising hydroxyapatite particles.
18. The apparatus of claim 17, wherein the substrate comprises a metal material selected from the group consisting of tantalum, cobalt, chromium, titanium, a tantalum alloy, a cobalt alloy, a chromium alloy, and a titanium alloy.
19. The apparatus of claim 17, wherein the substrate comprises a metal material and the metal material comprises titanium.
20. The apparatus of claim 19, wherein the metal material is a titanium alloy comprising six percent aluminum and four percent vanadium by weight.
21. The apparatus of claim 17, wherein the first coating layer is derived from an alkoxide having a ligand with a moiety that produces a positive surface charge.
22. The apparatus of claim 21, wherein the moiety comprises an amine.
23. The apparatus of claim 17, wherein the first coating layer has a property that bonds to the substrate.
24. The apparatus of claim 17, wherein the second coating layer comprises nanosized hydroxyapatite particles.
25. The apparatus of claim 17 wherein the second coating layer comprises at least three percent by weight hydroxyapatite.
26. The apparatus of claim 17, wherein the second coating layer comprises a negative surface charge.
27. The apparatus of claim 17
, wherein the alkoxide has the general formula:
where M is selected from one of silicon, titanium, baron, aluminum, and zirconium;
where R1 is an alkyl moiety;
where R2 is an organic moiety;
where Y is a positively charged ligand moiety; and
where x is the valence state of M.
This invention was made with United States Government support under contract 1R43DE14927-01 awarded by NIH/NIDCR. The Government has certain rights in this invention.
Metal implants are widely used in medical and dental applications, such as in orthopedic hip and knee surgeries and in dental surgery. Over two million orthopedic procedures and over 10 million dental implant procedures are performed in the United States every year. Implants fail because of poor osseointegration between the implant and the natural bone. Implants are typically made of metal materials, with titanium (Ti) and its alloys being favored due to their biocompatibility and mechanical properties. For the implants to function successfully, a direct chemical bond between the implant and the bone needs to form rapidly and needs to be retained over many years while the implant is loaded. Metal materials, however, do not form a direct chemical bond with bone. In order to promote osseointegration between the metal implant and bone, a layer of osseointegration promotion material is incorporated on the implant. Calcium phosphate ceramic materials are an example of coating materials that promote osseointegration. The most popular coating among the calcium phosphate family is hydroxyapatite (HA) due to its chemical stability and osteoconductivity.
Important parameters in the long-term behavior of implants coated with HA include at least acceptable coating-substrate bond strength and biostability (i.e., a low dissolution rate of the coating). In order to improve coating-substrate (usually a metal) bond strength and other properties, a variety of coating techniques have been explored to develop thin (generally less than 10 microns) coatings of HA and other calcium phosphates. U.S. Pat. No. 4,908,030 discloses a method of forming a thin HA coating on an implant using ion beam sputtering. U.S. Pat. No. 5,817,326 discloses a method in which one or more layers of HA sol-gel are cured to densify on a titanium alloy implant, followed by a non-line-of-sight ion implantation process, in order to strengthen the adhesion of the HA coating to the substrate. U.S. Pat. No. 5,543,019 discloses a method of forming a thin coating layer on the surface of an implant using a plasma sputtering process. Other methods developed include pulsed laser deposition and magnetron sputtering.
Another approach to improve the bonding capability of an HA coating onto a metallic substrate has been the deposition of a composite coating, wherein a metallic phase is introduced to serve as either an intermediate layer or a second (continuous or dispersed) phase in an HA matrix. For example, Dasarathy et al., in “Hydroxyapatite/metal composite coatings formed by electrocodeposition,” J. Biomed. Mater. Res., 31, 81–89 (1996), describes an electro-codeposition process to coat a cobalt/HA (Co/HA) composite coating on a Ti substrate with a bond strength up to 37 MPa. Using plasma spray technique, Brossa et al., in “Adhesion properties of plasma sprayed hydroxyapatite coatings for orthopaedic prostheses,” Bio-Med. Mater. Eng., 3, 127–136 (1993), and Nakashima et al., in “Hydroxyapatite coating on titanium-sprayed titanium implant,” in Bioceramics 6, P. Ducheyne and D. Christiansen (eds.), Butterworth-Heinemann, Oxford, 1993, pp. 449–453, describes a double-layer coating including an HA layer on top of a porous Ti precoat on a Ti substrate. This double-layered coating was shown to outperform a monolithic HA coating in adhesion properties. German patent “Coating of implants,” Gruner, Heiko (Plasmainevent A.-G.) Ger. Offen. DE 3,516,411 (C1. C23C4/04) Nov. 12, 1986, describes a multi-layered coating comprising a Ti precoat, a Ti/HA composite layer and an HA overlayer formed by plasma deposition. The multi-layer coated implants show fast and stable fusion between the coated implant and the bone. On Ti—6A1—4V substrate Ferraris et al., in “Vacuum plasma spray deposition of titanium particle/glass-ceramic matrix biocomposites,” J. Am. Ceram. Soc., 79, 1515–1520 (1996), plasma-sprayed a Ti particle-reinforced bioactive glass composite coating, which exhibited a higher bond strength than that of monolithic bioactive glass coating.
Pure titanium implants have become a preferred choice instead of calcium phosphate coated implants in recent years because of the critical disadvantages of previous calcium phosphate coatings. Plasma spraying and sputter coating are two major techniques that were widely used for HA coatings. These methods tend to have a problem with the dissolution of calcium phosphate, at a 50 percent rate, through a high temperature processing. Different phases of non-HA phosphate calcium sprayed on implants are easy to dissolute in body solution. The calcium phosphate coated implant by these methods also failed in long term stability often due to fracture at the coating-titanium interface which appeared to have been caused by the poor adherence of the HA film to the metal substrate. Furthermore, sputter plasma and coating tend to produce a non-uniform coating when they are applied to an irregular or porous surface.
Accordingly, a need exists for an implant with an improved bond strength and biostability as well as a method of forming such implants for use in orthopedic and dental applications. In addition, a majority of commercially available titanium implant systems utilize some degree of macroporous surface topography based on preclinical and clinical data that a roughened surface topography appears to enhance the rate and speed of functional implant-tissue integration. A conformer coating on the rough implant surface is needed.
A method is described. In one embodiment, the method is suitable for coating biocompatible, biostable, and bone conductive material of metal implant surfaces. An exemplary method includes forming a first coating layer on a portion of a substrate (e.g., a metal material) having a dimension suitable for an implant (e.g., a medical or dental implant), and forming a second coating layer on the first coating layer, the second coating layer, including a material having a property that promotes osseointegration.
For a multiple layer coating such as described, the first coating layer may be a single molecular layer that can react with a metal implant surface to promote or achieve chemical bonding or other adherence. In one embodiment, the first coating layer is made from alkoxides (such as alkoxysilanes) tri-functional silanes that tend to form a chemical bond to the metal implant. The reacted derivative may include a positively charged ligand on a surface of the formed layer or film. The second coating layer may be a layer of calcium phosphate material, such as nanosized hydroxyapatite particles, that may bond (e.g., ionically bond) or otherwise adhere to the positively charged first coating layer. In one embodiment, the second coating layer is made from a negatively charged hydroxyapatite (HA) nanoparticle, colloidal solution. Negative charged hydroxyapatite crystalline nanoparticles tend to form a relatively strong bond to the positively-charged first coating layer through ionic bonding forces. the attraction to the positively-charged first coating layer may also produce a negative charge at the surface of the second coating layer. Methods to immobilize bone inducing growth factors onto bone conductive hydroxyapatite that accelerates the fixation of the implant to the bone are also described.
An apparatus is further described. In one embodiment, an apparatus includes a substrate having a dimension suitable as an implant for use in a medical or dental application. The substrate may be a metal material such as titanium, tantalum, cobalt, chromium, and their respective alloys. Since it may be desirable, in one application to insert or embed (implant) the substrate into bone material, the substrate includes a surface coating over a portion thereof; representatively, at least the portion intended or designed to be in contact with bone or other tissue. In one embodiment, the surface coating includes at least two coating layers: a first coating layer having a property such that it will bond or otherwise adhere to the substrate, particularly a metal substrate; and a second coating layer on the first coating layer having a property that promotes osseointegration between the apparatus and bone or other tissue. Bone inducing growth factors may also be added, possibly to the second coating layer.
Additional features, embodiments, and benefits will be evident in view of the figures and detailed description presented herein.
BRIEF DESCRIPTION OF THE DRAWINGS
Features, aspects, and advantages of embodiments will become more thoroughly apparent from the following detailed description, appended claims, and accompanying drawings in which:
FIG. 1 schematically illustrates a cross-sectional side view of a portion of a substrate having multiple coating layers on a surface.
FIG. 2 shows a RT-PCR evaluation of steady state mRNA levels of type I collagen, osteopontin, osetocalcin, TO1, T02 and TO3 in rat bone marrow stromal cell cultured on Ti disks with turned, turned-HA, acid-etched, acid-etched-HA surfaces. A housekeeping gene, GAPDH was used as an internal control.
FIG. 3 shows an implant push-in test at day 14 of in vivo osseointegration in a rat femur. (n=6).
A coated apparatus and a method of coating an apparatus is disclosed. In one embodiment, a suitable apparatus is a medical/dental implant. An implant in this context means a device intended to be placed within a human body such as to connect skeletal structures (e.g., a hip implant) or to serve as a fixture for a body party (e.g., a fixture for an artificial tooth). FIG. 1 shows a medical/dental apparatus including substrate 10 of a metal material. A suitable metal material for a medical/dental implant includes, but is not limited to, a titanium, a tantalum, a cobalt, a chromium, or their respective alloys. One suitable alloy for titanium is a titanium (Ti)-aluminum (Al)-vanadium (V) alloy (e.g., Ti—6% Al—4% V). Substrate 10 includes surface 15 (top surface as viewed) that may or may not have an irregular topography or may be porous (e.g., macroporous).
Referring to FIG. 1, overlying a portion of surface 15 of substrate 10 is first coating layer 20, of, for example, a material having a property such that it will bond or otherwise associate or adhere to substrate 10. Suitable materials for first coating layer include, but are not limited to, materials derived from alkoxides. Representatively, first coating layer 20 is derived from an alkoxide having the general formula:
where M is one of silicon (Si), titanium (Ti), boron (B), aluminum (Al), zirconium or other ceramic types of metals;
where R1 is an alkyl moiety such as methyl or ethyl;
- where R2 is an organic moiety, such as an alkyl (e.g., methyl, ethyl), pyridin-benzene, benzene;
- where Y is a positively charged moiety, such as an amine (NH2) moiety or metal (e.g., Fe, Ca, Mg); and
- where x is the valence state of M.
One suitable material for use in forming first coating layer 20 is a multifunctional silane. Representatively, a suitable multifunctional alkoxysilane is a trifunctional silane, aminopropyl-trimethoxysilane (APS). APS tends to bond to a metal substrate through the alkoxy groups and provide a positively-charged surface through the amine-bonded ligand. (substrate-O—Si—R—NH+). An example of another positively charged ligand (YR2) that may be suitable is pyridin-Fe.
In one embodiment, first coating layer 20 is a single molecular layer (a monolayer) having, in this illustration, positively charged end ligands at a surface of the coating (the surface opposite substrate 10). First coating layer 20 may be formed on a portion of a surface of substrate including the entire surface. Suitable methods for forming first coating layer 20 include wet coating techniques such as dipping and spraying. For dip coating, a portion of the surface of substrate 10, including the entire surface, is immersed in an alkoxide solution in the presence of a catalyst and alcohol. The alkoxide may then undergo hydrolysis and condensation reactions to form a network (e.g., a polymeric network) of first coating layer 20 on the immersed surface.
Referring to FIG. 1, on first coating layer 20 (top surface as viewed) is second coating layer 30. In one embodiment, second coating layer 30 is a material that promotes osseointegration between substrate 10 and bone material (e.g., human bone material). One suitable material is a calcium phosphate material such as hydroxyapatite (HA). In one embodiment, second coating layer 30 is a layer including crystalline HA nanoparticles (e.g., having an average particle size on the order of an average particle size of 10 to 100 nanometers). One source of HA nanoparticles is Berkeley Advanced Biomaterials, Inc. of San Leandro, Calif. Representatively, BABI-HAP-N20™ has a particle size on the order of 20 nanometers.
The HA nanoparticles may be introduced on a surface of substrate 10 (on first coating layer 20) in the form of a colloid. To form a colloid, nanoparticles of HA may be combined (dispersed) in solution with a solvent and mixed at a pH on the order of 7 to 10. A representative amount of HA in a colloid is on the order of 0.15 weight percent.
The HA nanoparticles of second coating layer 30 have a property that tends to ionically-bond to first coating layer 20, particularly to positively-charged ligands of first coating layer 20. The ionic bonding creates a “self-assembled” coating (a combination of first coating layer 20 and second coating layer 30). A static charge attraction may be created on a surface of second coating layer 30 between the positively-charged ligands and appositively charged nanoparticles. Using HA nonoparticles as a material of second coating layer 30, a thin layer (e.g., a monolayer) has strong adhesion properties that promote osseointegration.
To form a coated substrate such as illustrated in FIG. 1, the substrate surface is initially thoroughly cleaned and charged (e.g., negatively charged) through chemical processing. First coating layer 20 is then applied to a portion of the surface substrate 10 by dipping or other wet coating process. Curing of first coating layer 20 may be done at room temperature in a matter of minutes. In the embodiment where first coating layer 20 is derived from (APS), a monolayer can provide a uniform one-dimensional distribution of cations is formed at the outermost surface of first coating layer 20. Substrate 10 including first coating layer 20 is then dipped into a solution including, in one embodiment, a colloid of HA, to form second coating layer 30 (e.g., an HA anionic layer). Representatively, substrate 10 may be immersed in an HA colloid solution for several minutes (e.g., 10 minutes) then rinsed and cured. Second coating layer 30 may be cured at a temperature of room temperature to about 100° C. To form additional layers of second coating layer material (e.g., multiple HA layers), the process may be repeated. A representative thickness for second coating layer 30 of one or more HA layers is on the order of 10 nanometers (e.g., one layer) to 100 nanometers. The multilayer coating (e.g., first coating layer 20 and second coating layer 30) thus formed can have a negatively charged surface. This ionic self-assembled multilayer coating or film also can be synthesized on virtually any shape implant and can provide a conformal coating on a rough metal (e.g., titanium) surface that may be maintained with the coating layer.
In one embodiment, the method applies sol-gel processing in a self-assembled method to produce a nanometer scale of calcium phosphate (e.g., HA) ultrathin-coating at room temperature to 200° C. A crystalline HA coating formed as described possesses high bioactivity and biocompatibility. The electrostatic nature of the coating improves adherence of an HA film to implant surfaces. The adherence is believed to be due to a chemically-bonded first or primary coating layer adjacent the metal implant and a second layer ionically bonded to the first layer. In one embodiment, a process produces a multilayer coating on the order of 10 nm to 200 nm thickness.
By using a calcium phosphate (e.g., HA) surface coating early and accelerated osteoblast adhesion may be generated thereby reducing the healing time during implantation, and should benefit patients with inadequate bones or significant load bearing implant designs, for whom no definite treatments are currently available. the coating described may also be non-toxic based on in vitro and in vivo assay. Results of an APS (first coating layer) and HA (second coating layer) coating indicate that genes associated with bone formation (col1, OPN, OCN) were equally expressed among the condition tested, while the implant specific genes were upregulated in HA coated discs as much as 50 percent.
The Hydroxyapatite (HA)—Sol Preparation:
HA nanopowder (˜20 nm) was used for formulation.
HA sol preparation: Materials: BABI-HAP-N20™ (100 g net weight in the ammonia hydroxide), ether, 2-methoxyethanol, and dH2O. Add 1 M NaOH and adjust the pH to 9–10. Move away the transparent solution on the top. Take the HA powder add in 2-methoxyethanol (3 percent). Ultrasonically agitate for 30 minutes at room temperature (RT) to make 3 percent HA colloid.
Self-Assembled Coating Preparation
Surface cleaning of Ti substrates: Preparation of Piranha solution: Add 45 ml 30 percent H2O2 and then 105 ml 100 percent H2SO4 (3:7) in a glass beaker of 200 ml. The resulting solution is divided to 3 parts and add in three glass bottles of 60 ml. Commercial implants are introduced into the solutions respectively. The bottles are then placed in an oven at 80° C. for 1 hour. Rinsing extensively with Milli-Q H2O. Rinsing again with absolute Ethanol. Drying in the oven.
APS modification of Ti surface: Preparation of 5 percent APS solution: Add 3-aminopropyltriethoxysilane in pure Toluene. Immerse the implants in 5 percent APS solution for 15 hours at RT. Ultrasonically agitate for 30 minutes each in toluene, methanol/toluene (1:1), and methanol. Rinsing extensively with Milli-Q water to remove residual APS. Dry at room temperature (RT) for 1 to 2 minutes and store till use.
Alkaloid water: Add NaOH in Milli-Q water and adjust the PH to 10.
Synthesis of Ultrathin Film of Hydroxyapatite:
Immerse the APS— modified titanium implants into 3 percent HA solution for 10 minutes at RT. Rinse by alkaloid dH2O. Cure at 100° C. for 30 minutes.
Cross-Cut Tap Test for Tensile Strength (Adhesion) of Ha Ultrathin Film on Titanium:
The adhesion of HA ultrathin film on metal titanium is tested by a Cross-Cut kit (Precision Gage & Tool Co., Ohio). Briefly, the specimens were placed on a firm base, under room temperature. An area free of blemishes and minor surface imperfections is selected, using the cross-cut tool from the lit to make parallel cuts. Make a second cut at 90 degree to and centered on the original cuts to create grid in the film. Place the center of the test tape over the grid and smooth it into place. To make good contact with the film, rub the tape firmly with a pencil eraser. Wait about 90 seconds, and then remove the tape. Seize the free end and quickly pull it back upon itself as close as possible to an 180 degree angle.
Using the kit's illuminated magnifier, inspect the grid area for removed coating. The adhesion of the coating is rated according to the following scale: 5B—none of the coating on the grid squares is detached; 4B—no more than approximately of the area is detached; 3B—approximately 5 to 15 percent of the area is detached. 2B: approximately 15 to 35 percent of the area is detached. 1B: approximately 35 to 65 percent of the area is detached. 0B: Flaking is worse than Grade 1B.
A grade of 5B was obtained for the coating formed as described in Examples 1–3 on the metal titanium and showed very strong adhesion of the coating.
Test for Cellular Toxicity of Nano-HA Coating In Vitro:
A disk including a coating formed as described in reference to Examples 1–3 was used for in vitro cell culture studies. Adult male Sprague-Dawley rats (approximately 100–150 g body weight) were used to isolate bone marrow stromal cells (BMSC). BMSC were divided in 4 groups and cultured on top of turned disk, acid-etched disk, turned-HA coated disk, and acid-etched-HA coated disk. BMSC were maintained in a conventional osteoblastic differentiation medium. BMSC proliferated uneventful on the HA surfaces and no significant difference were noted among the groups during the experimental period, suggesting that the coating formed as described do not exhibit any cellular toxicity. The culture was terminated at day 14 and BMSC were harvested for total RNA preparation. The steady state expression of mRNAs encoding bone extracellular matrix proteins and implant associated genes were evaluated by RT-PCR. FIG. 2 shows a RT-PCR evaluation of the steady state mRNA levels of type I collagen (col1), osteopontin (OPN), osteocalcin (OCN), TO1, TO2, and TO3 in rat bone marrow stromal cells. The expression levels of these mRNA species were similar in these groups. FIG. 2 also shows a housekeeping gene, GAPDH that was used as an internal control.
The results indicate that genes associated with bone formation (col1, OPN, OCN) were equally expressed among the condition tested, while the implant specific genes were upregulated in HA coated discs as much as 50 percent.
Cell Adhesion—Osseointegration In Vivo:
The miniature Ti rods with or without HA coating were UV sterilized and implanted in the femur of adult male Sprague-Dawley rats according to the previously described method. At day 14, the femurs were harvested and subjected to the implant push-in test. The HA coated titanium implant showed over a 200 percent increase of the push-in value as compared with the uncoated group. The results are illustrated in FIG. 3. This finding suggests that an HA coated structure coated as described in Examples 1–3 may positively stimulate osseointegration. The HA coated surface roughness was similar to uncoated titanium implant surface (Table 1).
In the preceding paragraphs, specific embodiments are described. It will, however, be evident that various modifications and changes may be made thereto without departing from the broader spirit and scope of the claims. The specification and drawings are, accordingly, to be regarded in an illustrative rather than a restrictive sense.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US4097935||Jan 31, 1977||Jul 4, 1978||Sterling Drug Inc.||Hydroxylapatite ceramic|
|US4131597||Jan 12, 1976||Dec 26, 1978||Ernst Leitz Gmbh||Bioactive composite material process of producing and method of using same|
|US4146936||Dec 29, 1976||Apr 3, 1979||Sumitomo Chemical Company Limited||Implants for bones, joints and tooth roots|
|US4223412||Dec 15, 1977||Sep 23, 1980||Sumitomo Chemical Company, Limited||Implants for bones, joints or tooth roots|
|US4330891||Feb 28, 1980||May 25, 1982||Branemark Per Ingvar||Element for implantation in body tissue, particularly bone tissue|
|US4366183||Jun 10, 1981||Dec 28, 1982||Societe Europeene De Propulsion||Process for making bioactive coatings on osseous prostheses, and prostheses thus obtained|
|US4451235||Apr 4, 1983||May 29, 1984||Kureha Kagaku Kogyo Kabushiki Kaisha||Process for preparing an artificial dental root|
|US4871578||Apr 4, 1988||Oct 3, 1989||Mtu Motoren- Und Turbinen-Union Muenchen Gmbh||Hydroxylapatite coating on metal or ceramic|
|US4882196||Mar 24, 1987||Nov 21, 1989||Permelec Electrode Ltd.||Process for the production of a titanium composite materials coated with calcium phosphate compound|
|US4904534||Jun 23, 1989||Feb 27, 1990||Kureha Kagaku Kogyo Kabushiki Kaisha||Implant material|
|US4908030||Apr 29, 1987||Mar 13, 1990||Vent-Plant Corporation, Inc.||Method of manufacturing synthetic bone coated surgical implants|
|US4911953||Sep 29, 1988||Mar 27, 1990||Permelec Electrode Ltd.||Process for producing composite materials having a coating of calcium phosphate compound|
|US4944754||Apr 26, 1988||Jul 31, 1990||Vent-Plant Corporation||Method of manufacturing synthetic bone coated surgical implants|
|US4960646||Apr 17, 1989||Oct 2, 1990||Permelec Electrode Ltd.||Titanium composite materials coated with calcium phosphate compound|
|US4965088||Mar 31, 1989||Oct 23, 1990||Permelec Electrode Ltd.||Calcium phosphate-coated composite material and process for production thereof|
|US4988362||Mar 7, 1989||Jan 29, 1991||Agency Of Industrial Science & Technology, Ministry Of International Trade & Industry||Composition for coating bioceramics, method for coating bioceramics therewith, and composite bioceramics produced therewith|
|US4990163||Feb 6, 1989||Feb 5, 1991||Trustees Of The University Of Pennsylvania||Method of depositing calcium phosphate cermamics for bone tissue calcification enhancement|
|US5030474||Aug 31, 1990||Jul 9, 1991||Sumitomo Chemical Company, Limited||Method for forming hydroxyapatite coating film using coating liquor containing hydroxyapatite|
|US5068122||Nov 8, 1989||Nov 26, 1991||Kyoto University||Process for forming a bioactive hydroxyapatite film|
|US5077132||Nov 7, 1989||Dec 31, 1991||Shigeo Maruno||Biocompatible composite material and a method for producing the same|
|US5092890||Dec 29, 1989||Mar 3, 1992||Basf Aktiengesellschaft||Implant materials for hard tissue|
|US5128169||Jan 2, 1991||Jul 7, 1992||Sumitomo Chemical Company, Limited||Method for forming hydroxyapatite coating film|
|US5188670 *||Apr 17, 1991||Feb 23, 1993||Norian Corporation||Apparatus for hydroxyapatite coatings of substrates|
|US5196201||Oct 19, 1990||Mar 23, 1993||Bioapatite Ab||Implant material composition, preparation thereof as well as uses thereof and implant product obtainable therefrom|
|US5205921||Feb 4, 1991||Apr 27, 1993||Queen's University At Kingston||Method for depositing bioactive coatings on conductive substrates|
|US5279831||Aug 21, 1992||Jan 18, 1994||Norian Corporation||Hydroxyapatite prosthesis coatings|
|US5344457||Feb 2, 1993||Sep 6, 1994||The University Of Toronto Innovations Foundation||Porous surfaced implant|
|US5344654||Jun 16, 1992||Sep 6, 1994||Stryker Corporation||Prosthetic devices having enhanced osteogenic properties|
|US5478237||Jun 25, 1993||Dec 26, 1995||Nikon Corporation||Implant and method of making the same|
|US5501706||Nov 29, 1994||Mar 26, 1996||Wildflower Communications, Inc.||Medical implant structure and method for using the same|
|US5527837||Apr 24, 1995||Jun 18, 1996||Shin-Etsu Chemical Co., Ltd.||Heat-curable silicone elastomer compositions|
|US5543019||Feb 6, 1995||Aug 6, 1996||Etex Corporation||Method of coating medical devices and device coated thereby|
|US5558517||Jul 15, 1994||Sep 24, 1996||Clemson University||Polymeric prosthesis having a phosphonylated surface|
|US5571188||Dec 1, 1993||Nov 5, 1996||Astra Aktiebolag||Process for treating a metallic surgical implant|
|US5584875||Apr 13, 1994||Dec 17, 1996||C. R. Bard, Inc.||Method for making vascular grafts|
|US5609633||Nov 9, 1994||Mar 11, 1997||The Foundation For Promotion Of Ion Engineering||Titanium-based bone-bonding composites having inverted concentration gradients of alkali and titanium ions in a surface layer|
|US5612049 *||Apr 21, 1993||Mar 18, 1997||Axidental Oy||Bioactive coatings and their preparation and use|
|US5652016||Apr 2, 1996||Jul 29, 1997||Osaka Cement Co., Ltd.||Tetracalcium phosphate-based materials and processes for their preparation|
|US5700289||Oct 20, 1995||Dec 23, 1997||North Shore University Hospital Research Corporation||Tissue-engineered bone repair using cultured periosteal cells|
|US5722439||Feb 26, 1996||Mar 3, 1998||Endelson; Robert A.||Dental floss dispenser on card format|
|US5730598||Mar 7, 1997||Mar 24, 1998||Sulzer Calcitek Inc.||Prosthetic implants coated with hydroxylapatite and process for treating prosthetic implants plasma-sprayed with hydroxylapatite|
|US5733564||Apr 12, 1994||Mar 31, 1998||Leiras Oy||Method of treating endo-osteal materials with a bisphosphonate solution|
|US5759376||Sep 6, 1995||Jun 2, 1998||Dot Dunnschicht- Und Oberflaechen-Technologie Gmbh||Method for the electrodeposition of hydroxyapatite layers|
|US5759598||Mar 11, 1997||Jun 2, 1998||Nestec S.A.||Fermented food product for animals|
|US5763092||Jan 2, 1996||Jun 9, 1998||Etex Corporation||Hydroxyapatite coatings and a method of their manufacture|
|US5766247||Dec 8, 1994||Jun 16, 1998||Kabushiki Kaisya Advance||Process for producing a bioimbedding material|
|US5772439||Mar 27, 1996||Jun 30, 1998||Kanebo Limited||Hybrid dental implant|
|US5807430||Nov 6, 1995||Sep 15, 1998||Chemat Technology, Inc.||Method and composition useful treating metal surfaces|
|US5817326||Dec 1, 1995||Oct 6, 1998||The Regents Of The University Of California||Processing of hydroxylapatite coatings on titanium alloy bone prostheses|
|US5858318||Nov 27, 1996||Jan 12, 1999||Luo; Ping||Methods of synthesizing hydroxyapatite powders and bulk materials|
|US5934287||Jun 29, 1998||Aug 10, 1999||Brainbase Corporation||Implant with bioactive particles stuck and method of manufacturing the same|
|US5952399||Sep 30, 1997||Sep 14, 1999||Degussa Aktiengesellschaft||Polymerisable dental material and use of apatite fillers in the dental material|
|US5958340||Jun 5, 1998||Sep 28, 1999||Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V.||Solid-state chemical sensor|
|US5958504||Dec 18, 1996||Sep 28, 1999||Etex Corporation||Hydroxyapatite coatings and a method of their manufacture|
|US5962549||Dec 9, 1997||Oct 5, 1999||University Of London||Bioactive composite material for repair of hard and soft tissues|
|US5981619||Sep 13, 1996||Nov 9, 1999||Takiron Co., Ltd.||Material for osteosynthesis and composite implant material, and production processes thereof|
|US5990381||Nov 12, 1997||Nov 23, 1999||Ise International, Co., Ltd.||Biomedical materials|
|US6013591||Jan 16, 1998||Jan 11, 2000||Massachusetts Institute Of Technology||Nanocrystalline apatites and composites, prostheses incorporating them, and method for their production|
|US6051272||Feb 9, 1999||Apr 18, 2000||The Board Of Trustees Of The University Of Illinois||Method for synthesizing organoapatites on to surgical metal alloys|
|US6077989||May 15, 1997||Jun 20, 2000||Kandel; Rita||Resorbable implant biomaterial made of condensed calcium phosphate particles|
|US6129928||Sep 4, 1998||Oct 10, 2000||Icet, Inc.||Biomimetic calcium phosphate implant coatings and methods for making the same|
|US6136369||Apr 23, 1999||Oct 24, 2000||Isotis B.V.||Device for incorporation and release of biologically active agents|
|US6139585||Mar 11, 1998||Oct 31, 2000||Depuy Orthopaedics, Inc.||Bioactive ceramic coating and method|
|US6143948||Jul 3, 1997||Nov 7, 2000||Isotis B.V.||Device for incorporation and release of biologically active agents|
|US6146686||Apr 23, 1999||Nov 14, 2000||Isotis B.V.||Implant material and process for using it|
|US6146767||Feb 4, 1997||Nov 14, 2000||The Trustees Of Princeton University||Self-assembled organic monolayers|
|US6153266||Dec 7, 1998||Nov 28, 2000||Japan As Represented By Director General Agency Of Industrial Science And Technology||Method for producing calcium phosphate coating film|
|US6153664||Oct 7, 1998||Nov 28, 2000||Cambridge Scientific, Inc.||Bioerodible polymeric semi-interpenetrating network alloys and internal fixation devices made therefrom|
|US6183255||Mar 27, 2000||Feb 6, 2001||Yoshiki Oshida||Titanium material implants|
|US6190412||Apr 21, 1998||Feb 20, 2001||Washington Research Foundation||Trap-coated bone grafts and prostheses|
|US6200137||Jun 12, 1998||Mar 13, 2001||Ivoclar Ag||Chemically stable translucent apatite glass ceramic|
|US6206598||Sep 27, 1999||Mar 27, 2001||Samuel V. Johnson||Capping device|
|US6261322||May 14, 1998||Jul 17, 2001||Hayes Medical, Inc.||Implant with composite coating|
|US6270347||Jun 5, 2000||Aug 7, 2001||Rensselaer Polytechnic Institute||Nanostructured ceramics and composite materials for orthopaedic-dental implants|
|US6280789||Apr 21, 1997||Aug 28, 2001||Biocoatings S.R.L.||Process for preparation of hydroxyapatite coatings|
|US6280863||Jun 12, 1998||Aug 28, 2001||Ivoclar Ag||Translucent apatite glass ceramic|
|US6290982||Dec 16, 1997||Sep 18, 2001||Jvs-Polymers Oy||Plasticizable implant material and method for producing the same|
|US6306784||Jun 9, 2000||Oct 23, 2001||Ivoclar Ag||Alkali silicate glass|
|US6306925||Dec 18, 1998||Oct 23, 2001||Usbiomaterials Corporation||Tape cast multi-layer ceramic/metal composites|
|US6338810||Dec 22, 1998||Jan 15, 2002||Commissariat A L'energie Atomique||Method for making apatite ceramics, in particular for biological use|
|US6344061||Jul 26, 2000||Feb 5, 2002||Isotis N.V.||Device for incorporation and release of biologically active agents|
|US6344209||Apr 23, 1998||Feb 5, 2002||Takeda Chemical Industries, Ltd.||Apatite-coated solid composition|
|US6344276||May 19, 1999||Feb 5, 2002||Jiin-Huey Chern Lin||Non-dissolvable amorphous Ti-Ca-P coating for implant application|
|US6372354||Sep 13, 1999||Apr 16, 2002||Chemat Technology, Inc.||Composition and method for a coating providing anti-reflective and anti-static properties|
|US6395299 *||Feb 14, 2000||May 28, 2002||Biostream, Inc.||Matrices for drug delivery and methods for making and using the same|
|US6399215||Mar 28, 2000||Jun 4, 2002||The Regents Of The University Of California||Ultrafine-grained titanium for medical implants|
|US6419708||Apr 29, 1998||Jul 16, 2002||Nobel Biocare Ab||Calcium-phosphate coated implant element|
|US6426114||May 2, 2000||Jul 30, 2002||The University Of British Columbia||Sol-gel calcium phosphate ceramic coatings and method of making same|
|US6428803||Nov 30, 1999||Aug 6, 2002||Rolf Ewers||Hydroxylapatite gel|
|US6508838||Feb 16, 2001||Jan 21, 2003||Washington Research Foundation||Compositions for medical implantation|
|US6527849 *||Jul 17, 2001||Mar 4, 2003||Carolyn M. Dry||Self-repairing, reinforced matrix materials|
|US6530958||Jun 5, 1995||Mar 11, 2003||Massachusetts Institute Of Technology||Tissue regeneration matrices by solid free-form fabrication techniques|
|US6569292||Apr 4, 2001||May 27, 2003||Texas Christian University||Method and device for forming a calcium phosphate film on a substrate|
|US6569489||May 19, 2000||May 27, 2003||Depuy Orthopaedics, Inc.||Bioactive ceramic coating and method|
|US6589590||Feb 27, 2002||Jul 8, 2003||Isis Innovation Limited||Composite material and methods of making the same|
|US6596338||Oct 24, 2001||Jul 22, 2003||Howmedica Osteonics Corp.||Antibiotic calcium phosphate coating|
|US6617142 *||Feb 24, 1999||Sep 9, 2003||Medtronic, Inc.||Method for attachment of biomolecules to medical device surfaces|
|US6620861||Nov 17, 2000||Sep 16, 2003||Kabushiki Kaisha Shofu||Dental fillers|
|US6645644||Sep 22, 2000||Nov 11, 2003||The Trustees Of Princeton University||Enhanced bonding of phosphoric and phosphoric acids to oxidized substrates|
|US6740366 *||Dec 19, 2001||May 25, 2004||Nippon Sheet Glass Co., Ltd.||Article having predetermined surface shape and method for preparing the same|
|US20010020476 *||Apr 12, 2001||Sep 13, 2001||The Trustees Of The University Of Pennsylvania||Compositions and methods for intervertebral disc reformation|
|US20020018798||Jun 21, 2001||Feb 14, 2002||Merck Patent Gesellschaft Mit Beschrankter Haftung||Coating for metallic implant materials|
|US20020127391||Dec 15, 2000||Sep 12, 2002||Mukesh Kumar||Coated resorbable polymer and method of making the same|
|US20030005646 *||Jul 9, 2001||Jan 9, 2003||Mchale James M.||Surface modification of coated abrasives to enhance their adhesion in resin bond tools|
|US20030099762||Oct 14, 2002||May 29, 2003||Zongtao Zhang||Coatings, coated articles and methods of manufacture thereof|
|US20030219466 *||Mar 19, 2003||Nov 27, 2003||Kumta Prashant N.||Method of manufacturing hydroxyapatite and uses therefor in delivery of nucleic acids|
|US20030219562 *||Feb 14, 2003||Nov 27, 2003||Frantisek Rypacek||Polymer coating for medical devices|
|US20030231984 *||May 7, 2003||Dec 18, 2003||Bright Frank V.||Method to rapidly prepare and screen formulations and compositions containing same|
|US20040023048 *||Apr 1, 2003||Feb 5, 2004||Jeffrey Schwartz||Enhanced bonding layers on native oxide surfaces|
|US20040121451 *||Mar 15, 2002||Jun 24, 2004||Niko Moritz||Treatment of sols, gels and mixtures thereof|
|US20050008620 *||Oct 8, 2003||Jan 13, 2005||Shimp Lawrence A.||Coupling agents for orthopedic biomaterials|
|DE3516411A1||May 7, 1985||Nov 13, 1986||Plasmainvent Ag||Beschichtung eines implantatkoerpers|
|EP1275422A2||Jul 10, 2002||Jan 15, 2003||Konami Computer Entertainment Osaka, Inc.||Recording medium storing three-dimensional image processing program, three-dimensional image processing program, method and device|
|1||Brossa et al., "Adhesion properties of plasma sprayed hydroxylapatite coatings for orthopaedic prostheses," Bio-Med. Mater. and Eng., vol. 3, No. 3, 127-136 (1993).|
|2||Dasarathy et al., "Hydroxyapatite/metal composite coatings fromed by electrocodeposition," J. Biomed. Mater. Res., vol. 31, 81-89 (1996).|
|3||Ferraris et al, "Vacuum Plasma Spray Deposition of Titanium Particle/Glass-Ceramic Matrix Biocomposites," J. Am. Ceram. Soc., 79 , 1515-20 (1996).|
|4||Nakashima et al., "Hydroxyapatite Coating on Titanium-Sprayed Titanium Implant," Bioceramics, vol. 6, P. Ducheyne and D. Christiansen (eds.), Butterworth-Heinemann Ltd, 1993, 449-453.|
|5||PCT Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration, Dec. 3, 2004.|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US7341756 *||Feb 22, 2006||Mar 11, 2008||Chemat Technology, Inc.||Coated implants and methods of coating|
|US7740940 *||Nov 14, 2007||Jun 22, 2010||Aculon, Inc.||Coated substrates, organometallic films and methods for applying organometallic films to substrates|
|US7901777||Apr 23, 2010||Mar 8, 2011||Aculon, Inc.||Coated substrates, organometallic films and methods for applying organometallic films to substrates|
|US7972648||Oct 24, 2007||Jul 5, 2011||Biomet 3I, Llc||Deposition of discrete nanoparticles on a nanostructured surface of an implant|
|US8337985||Dec 15, 2010||Dec 25, 2012||Aculon, Inc.||Coated substrates, organometallic films and methods for applying organometallic films to substrates|
|US8647118||May 18, 2011||Feb 11, 2014||Biomet 3I, Llc||Deposition of discrete nanoparticles on a nanostructured surface of an implant|
|US20140127392 *||Jan 9, 2014||May 8, 2014||Biomet 3I, Llc||Deposition of discrete nanoparticles on a nanostructured surface of an implant|
|Dec 27, 2013||FPAY||Fee payment|
Year of fee payment: 8
|Dec 28, 2009||FPAY||Fee payment|
Year of fee payment: 4
|Aug 7, 2007||CC||Certificate of correction|
|Jan 14, 2004||AS||Assignment|
Owner name: CHEMAT TECHNOLOGY, INC., CALIFORNIA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LIU, JIANKAI;HUANG, YUHONG;NISHIMURA, ICHIRO;REEL/FRAME:014259/0738
Effective date: 20030603
|Jun 4, 2003||AS||Assignment|
Owner name: CHEMET TECHNOLOGY INC., CALIFORNIA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LIU, JIANKAI;HUANG, YUHONG;NISHIMURA, ICHIRO;REEL/FRAME:014142/0497
Effective date: 20030603